The Role of Ofatumumab in Chronic Lymphocytic Leukemia Treatment
4 Views
administrator
07/08/23
The panelists, William G. Wierda, MD, PhD; Alessandra Ferrajoli, MD; Susan M. O’Brien, MD; Thomas J. Kipps, MD, PhD; and Richard F. Furman, MD, examine the management of infusion reactions and the role of ofatumumab in the treatment of chronic lymphocytic leukemia.
-
Category
Show more
Facebook Comments
No comments found